Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies

Abroad (travel likely)Recruiting

Conditions

Acute Myeloid Leukemia · Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Hospital of Angers, Angers, Maine et Loire, France
Contact: Study coordinator (Darras Elise, PharmD) · Elise.Darras@chu-angers.fr · 241355925
Contact: Study coordinator (AUBE-NATHIER Anne-Catherine, PhD) · acaube-nathier@chu-angers.fr · 241355496
Contact: Principal Investigator (SCHMIDT ALINE, MD, PHD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

National Longitudinal Cohort of Hematological Diseases

Multiple Myeloma · Acute Myeloid Leukemia · Hemophilia

Abroad (travel likely)Recruiting

Tianjin, China

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML

AML (Acute Myeloid Leukemia)

Abroad (travel likely)RecruitingPHASE3

Kunming, China

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Duarte, United States